Patent · US Expired

.beta.-1,4-galactanase and a DNA sequence

US5474922A · kind A · utility

3Cited by

4References

11Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Kurt Dorreich · Weil am Rhein, DE
Henrik Dalboge · Avenue Madeleine, DK
Jan M. Mikkelsen · Copenhagen, DK
Marcel Mischler · Himmelried, CH
Flemming M. Christensen · Hørsholm, DK

Key dates

Filing date	Jul 15, 1993
Grant date	Dec 12, 1995
Priority date	—
Expiry date	Jul 15, 2013

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S435/913
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to .beta.-1,4-galactanase derived from A. aculeatus which have (a) a pH-optimum between 3.0 and 5.0, (b) an isoelectric point of 2.5-3.5, (c) a molecular weight of between 30,000 and 50,000, and (d) a temperature optimum between 10.degree. and 50.degree. C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.